These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11140782)

  • 1. Obsessive-complusive disorder: pharmacological treatment.
    Thomsen PH
    Eur Child Adolesc Psychiatry; 2000; 9 Suppl 1():I76-84. PubMed ID: 11140782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder.
    Pigott TA; Seay SM
    J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal treatment for obsessive compulsive disorder: a randomized controlled feasibility study of the clinical-effectiveness and cost-effectiveness of cognitive-behavioural therapy, selective serotonin reuptake inhibitors and their combination in the management of obsessive compulsive disorder.
    Fineberg NA; Baldwin DS; Drummond LM; Wyatt S; Hanson J; Gopi S; Kaur S; Reid J; Marwah V; Sachdev RA; Pampaloni I; Shahper S; Varlakova Y; Mpavaenda D; Manson C; O'Leary C; Irvine K; Monji-Patel D; Shodunke A; Dyer T; Dymond A; Barton G; Wellsted D
    Int Clin Psychopharmacol; 2018 Nov; 33(6):334-348. PubMed ID: 30113928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Is the Added Benefit of Combining Cognitive Behavioral Therapy and Selective Serotonin Reuptake Inhibitors in Youth with Obsessive Compulsive Disorder? A Bayesian Hierarchical Modeling Meta-Analysis.
    Mendez EM; Dahlsgaard KK; Hjelmgren JM; Mills JA; Suresh V; Strawn JR
    J Child Adolesc Psychopharmacol; 2023 Aug; 33(6):203-211. PubMed ID: 37347947
    [No Abstract]   [Full Text] [Related]  

  • 5. Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: a meta-analysis.
    Issari Y; Jakubovski E; Bartley CA; Pittenger C; Bloch MH
    J Clin Psychiatry; 2016 May; 77(5):e605-11. PubMed ID: 27249090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Review and Meta-Analysis: Early Treatment Responses of Selective Serotonin Reuptake Inhibitors and Clomipramine in Pediatric Obsessive-Compulsive Disorder.
    Varigonda AL; Jakubovski E; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2016 Oct; 55(10):851-859.e2. PubMed ID: 27663940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults.
    Greist JH; Bandelow B; Hollander E; Marazziti D; Montgomery SA; Nutt DJ; Okasha A; Swinson RP; Zohar J;
    CNS Spectr; 2003 Aug; 8(8 Suppl 1):7-16. PubMed ID: 14767394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents.
    Figueroa Y; Rosenberg DR; Birmaher B; Keshavan MS
    J Child Adolesc Psychopharmacol; 1998; 8(1):61-7. PubMed ID: 9639080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial.
    Pediatric OCD Treatment Study (POTS) Team
    JAMA; 2004 Oct; 292(16):1969-76. PubMed ID: 15507582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological treatment of children and adolescents with OCD].
    Thomsen H
    Ugeskr Laeger; 2001 Jul; 163(27):3763-8. PubMed ID: 11466982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children/adolescents and adults.
    Skapinakis P; Caldwell D; Hollingworth W; Bryden P; Fineberg N; Salkovskis P; Welton N; Baxter H; Kessler D; Churchill R; Lewis G
    Health Technol Assess; 2016 Jun; 20(43):1-392. PubMed ID: 27306503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Course of obsessive-compulsive disorder in children and adolescents: a prospective follow-up study of 23 Danish cases.
    Thomsen PH; Mikkelsen HU
    J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1432-40. PubMed ID: 8543510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological treatments for obsessive-compulsive disorder in children and adolescents: a qualitative review.
    Rosa-Alcázar AI; Iniesta-Sepúlveda M; Rosa-Alcázar A
    Actas Esp Psiquiatr; 2013; 41(3):196-203. PubMed ID: 23803803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obsessive-compulsive disorder: a new perspective in diagnosis and treatment.
    Lydiard RB
    Int Clin Psychopharmacol; 1994 Jun; 9 Suppl 3():33-7. PubMed ID: 7963449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in the treatment of obsessive-compulsive disorder.
    Leonard HL
    J Clin Psychiatry; 1997; 58 Suppl 14():39-45; discussion 46-7. PubMed ID: 9418745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).
    Del Casale A; Sorice S; Padovano A; Simmaco M; Ferracuti S; Lamis DA; Rapinesi C; Sani G; Girardi P; Kotzalidis GD; Pompili M
    Curr Neuropharmacol; 2019; 17(8):710-736. PubMed ID: 30101713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder.
    March JS; Franklin ME; Leonard H; Garcia A; Moore P; Freeman J; Foa E
    Biol Psychiatry; 2007 Feb; 61(3):344-7. PubMed ID: 17241830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Obsessive-compulsive disorder in children and adolescents: a literature review. Part II].
    Bryńska A
    Psychiatr Pol; 1998; 32(1):77-88. PubMed ID: 9594586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A Review and Recommendations of Evidence-Based Treatments for Pediatric Obsessive-Compulsive Disorder].
    Skarphedinsson G; Lauth B; Njardvik U; Ivarsson T
    Laeknabladid; 2016 Apr; 102(4):179-85. PubMed ID: 27197125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Systematic Review of Evidence-based Treatment Strategies for Obsessive- compulsive Disorder Resistant to first-line Pharmacotherapy.
    Albert U; Marazziti D; Di Salvo G; Solia F; Rosso G; Maina G
    Curr Med Chem; 2018; 25(41):5647-5661. PubMed ID: 29278206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.